At a pharma rep industry exchange meeting, someone asked first: "What difficulties have you encountered recently when visiting customers?"
Rep A was the first to describe the problem: a new customer had been assigned, the customer did not know them yet, and they had no idea where to start the conversation during a visit.
Then Rep B, who was responsible for existing customers, also complained that even after years of contact, some customers still made academic cooperation difficult, and speaker invitations were repeatedly blocked.
Rep C had a new worry: the company was recently doing digital intelligence marketing and had prepared large amounts of professional content for reps to distribute. But reps did not know which content suited which customer, so they could only push blindly to complete tasks and ask for clicks through face-to-face familiarity. Enablement instead became work burden.
The sales teams' difficulties seemed different, and then MeDomino's Damai bot appeared.
For the challenge of breaking the ice with new customers, Damai proposed a solution: precisely provide the new customer's dynamics, interests, preferences, and recommended visit timing to help sales reps quickly find communication entry points.
For speaker invitation challenges, Damai suggested that using the customer's collaboration circle and topic fields could greatly reduce invitation difficulty.
For content push pain points, Damai proposed matching suitable content by customer interests and attitude stage, then generating dedicated push wording, turning content push from a burden into efficient enablement.
The reps' difficulties seemed different, but the core was the same: lack of deep customer insight. With AI large models, MeDomino analyzes HCP internal and external data and enterprise knowledge bases, effectively judging customer interests, circles, preferences, and attitudes, and enabling customer insight, intelligent content recommendation, and precise wording generation.
This global top pharma company has cooperated continuously with MeDomino for more than five years. Disease areas have expanded from the initial hepatitis field to the full product line, and MeDomino HCP360 has become a core enablement lever for its sales team.
Currently, more than 70% of the company's reps actively use MeDomino HCP360. Rep work is easier, and marketing results are more significant.
To request a demo or learn more case details, please contact MeDomino.
